MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/ijgo.13961

Медицинская библиотека · International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2021

Is cytology/HPV co-testing for cervical cancer screening useful in Japan?

Oishi Tetsuro, Kigawa Junzo, Iwanari Osamu, Kasai Tokuzo, Kurokawa Tetsuji, Hamada Masao, Fujita Hiromasa, Fujiwara Hiroyuki, Yokoyama Masatoshi, Sakuragi Noriaki, Harada Tasuku, Suzuki Mitsuaki

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVE

In Japan, no region has introduced primary HPV testing for cervical cancer screening. We assessed the diagnostic value and possible harm of HPV testing in Japan.

METHODS

This cross-sectional study with historical controls used cytology-based screening and co-testing data in Japan. As surrogate indicators of possible harm, colposcopy referral rate and cervical intraepithelial neoplasm (CIN) 1 detection rates were calculated. As surrogate indicators with diagnostic values, the detection rates of CIN2 or greater (CIN2+) and CIN3+ were calculated.

RESULTS

The data of 297 970 women (182 697 for cytology-based, 115 273 for co-testing) were examined. The detection rates of CIN1, CIN2+, and CIN3+ were significantly higher in the co-testing group than in the cytology-based group (P < 0.001, P < 0.0001, P < 0.01, respectively). Between ages 25-49, CIN2+ detection rates were significantly higher in the co-testing group than in the cytology-based group (P < 0.05 for each 5-year age group). Between ages 30-49, CIN3+ detection rates were significantly higher in the co-testing group than in the cytology-based group (P < 0.05 for each 5-year age group).

CONCLUSION

Limiting the target age group may minimize the possible harm of screening. Cytology/HPV co-testing may be useful in Japanese populations if balance is maintained between benefit and harm.

Для цитирования: Oishi Tetsuro, Kigawa Junzo, Iwanari Osamu, Kasai Tokuzo, Kurokawa Tetsuji, Hamada Masao, Fujita Hiromasa, Fujiwara Hiroyuki, Yokoyama Masatoshi, Sakuragi Noriaki, Harada Tasuku, Suzuki Mitsuaki. Is cytology/HPV co-testing for cervical cancer screening useful in Japan?. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2021. DOI: 10.1002/ijgo.13961.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.